the impact of salvage and bridging therapy on car t-cell therapy outcomes in b-all: an itt analysis
Published 6 months ago • 133 plays • Length 3:03Download video MP4
Download video MP3
Similar videos
-
1:51
checkpoint inhibition in the treatment of mpns
-
4:33
impact of covid-19 on hsct and cellular therapies in the us
-
2:18
redirecting t-cell cytotoxicity and proliferation
-
2:16
the impact partnership: improving regulation and turnaround of transplant clinical trials
-
25:06
evolving landscape of targeted therapies | dr. lizza hendriks
-
1:30
targeting the complement cascade in autoimmune hemolytic anemias
-
5:22
protecting the patient - finnish version
-
34:36
highlights from asco / eha 2021: latest updates on myeloma
-
1:02
hss minute: adverse event management for checkpoint inhibitors
-
5:13
masterclass workshop haematology hands-on course point pf care coagulation
-
2:38
impact: expediting transplantation trials
-
5:12
saving limbs, saving lives: peripheral artery disease
-
31:13
the sustainable impact of a standardised approach to lower limb wound care
-
1:36
donor impact on the frontline 2022
-
1:06
a widespread impact
-
3:05
the case for providing care immediately following an acute stroke
-
3:58
complement inhibition for the treatment of ta-tma
-
1:02:24
lymphedema management and risk reduction
-
39:32
phalangeal fractures by dr wolfgang hintringer